Clinical trials
Recruiting Phase 4 Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Duke University | 2 |
| Asan Medical Center | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Drahomir Aujesky | 1 |
| Erasmus Medical Center | 1 |
| Jung-min Ahn | 1 |
| Malamo Countouris | 1 |
| National Heart Centre Singapore | 1 |
| Per Løgstrup Poulsen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 25 |
| Hemorrhage | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Embolism and Thrombosis | 3 |
| Hypertension | 3 |
| Stroke | 3 |
| Atherosclerosis | 2 |
| Coronary Artery Disease | 2 |
| Kidney Diseases | 2 |
| Mitral Valve Insufficiency | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.